Page 139 - Read Online
P. 139
De Gaspari et al. Vessel Plus 2022;6:57 https://dx.doi.org/10.20517/2574-1209.2022.05 Page 13 of 13
82. Audet A, Côté N, Couture C, et al. Amyloid substance within stenotic aortic valves promotes mineralization. Histopathology
2012;61:610-9. DOI PubMed
83. Iwata T, Nakamura H, Nagasawa T, et al. Amyloid deposits in heart valves. Acta Pathol Jpn 1982;32:23-9. DOI PubMed
84. Goffin YA, Murdoch W, Cornwell GG 3rd, Sorenson GD. Microdeposits of amyloid in sclerocalcific heart valves: a histochemical and
immunofluorescence study. J Clin Pathol 1983;36:1342-9. DOI PubMed PMC
85. James TN. Pathology of the cardiac conduction system in amyloidosis. Ann Intern Med 1966;65:28-36. DOI
86. Ridolfi RL, Bulkley BH, Hutchins GM. The conduction system in cardiac amyloidosis. The American Journal of Medicine
1977;62:677-86. DOI PubMed
87. Yuda S, Hayashi T, Yasui K, et al. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in
Patients with Systemic Light Chain Amyloidosis. Intern Med 2015;54:1833-40. DOI PubMed
88. Georgin-Lavialle S, Guellich A, Deux JF, Buob D, Damy T. Isolated Pericardial Infiltration Without Myocardial Involvement in Light-
Chain-Related Amyloidosis. Ann Thorac Surg 2017;103:e255-7. DOI PubMed
